Neurogene Cash Flow Statement (2013-2026) | NGNE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-41.41M	-33.83M	-40.37M	-15.39M	-15.94M	-13.70M	-49.84M	-12.26M	-11.87M	-14.57M	-13.96M	-48.66M	-31.60M	-40.34M	-23.11M	-23.41M	-24.65M	-23.96M	-24.86M	-38.29M
Share-based Compensation (Quarter)	2.92M	-3.75M	9.97M	2.45M	2.31M	2.03M	-5.54M	0.29M	-0.29M	1.06M	0.35M	0.06M		5.77M	-5.77M	4.05M	-4.05M			3.63M
Asset Writedowns and Impairment (Quarter)										0.10M		0.09M							0.12M
Cash from Operations (Quarter)	-13.28M	-8.76M	-12.17M	-14.09M	-11.29M	-9.29M	-18.13M	-13.55M	-9.35M	-11.55M	-16.97M	-21.65M	-15.89M	-15.56M	-17.50M	-20.77M	-19.43M	-19.50M	-17.47M	-26.10M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)					-0.00M	0.11M	-0.10M		0.01M	0.01M	0.10M	0.01M	0.02M	0.01M	2.38M	0.01M	0.01M	0.01M	0.50M	0.01M
Amortization of Deferred Charges (Quarter)	0.23M	0.24M	0.24M	0.25M	0.26M	0.27M	0.28M	0.29M	0.29M	0.30M
Depreciation & Amortization (CF) (Quarter)	0.31M	0.36M	0.39M	0.41M	0.46M	0.32M	2.01M	0.80M	0.80M	0.80M	0.90M	0.80M	0.80M	0.80M	0.79M	0.75M	0.80M	0.80M	0.73M	0.80M
Change in Working Capital
Change in Receivables (Quarter)
Change in Account Payables (Quarter)								0.82M	0.03M	0.66M	-0.84M	0.14M	0.23M	-0.03M	-0.42M	1.69M	-0.97M	-0.50M	0.41M	2.42M
Change in Accured Expenses (Quarter)	-0.53M	1.49M	-0.47M	-0.77M	1.38M	1.21M	-1.02M	-2.44M	1.16M	1.38M	-3.66M	-4.88M	0.21M	2.64M	-0.74M	-2.20M	2.17M	0.36M	1.33M	0.36M
Other Working Capital Changes (Quarter)	-1.78M	-0.25M	-0.26M	-0.28M	-0.29M	-0.30M	0.25M	-0.16M	-0.17M	-0.17M	-0.18M	-0.61M	-0.63M	-0.65M	-0.68M	-0.71M	-0.73M	-0.74M	-0.74M	-0.76M
Investing Activities
Capital Expenditures (Quarter)	-0.38M	-0.12M	0.12M	0.09M	0.59M	0.32M	1.22M	0.03M	0.08M	0.08M	0.13M	0.14M	0.38M	0.18M	0.02M	0.78M	0.15M	0.13M	-0.98M	0.28M
Sales of Property, Plant and Equipment (Quarter)
Change in Acquisitions & Divestments (Quarter)						15.00M	-15.00M				5.00M	30.00M	19.50M	8.75M	15.75M	44.70M	68.00M	99.50M	72.50M	130.00M
Cash from Investing Activities (Quarter)	-1.19M	-0.59M	-0.40M	-0.45M	-39.30M	-27.85M	65.37M	-0.03M	-0.08M	-0.08M	25.83M	29.93M	-23.61M	-28.97M	-102.62M	-45.05M	7.45M	21.99M	29.61M	46.24M
Financing Activities
Other financing activities (Quarter)	-0.06M	0.19M	-0.04M	0.13M	-0.07M	0.07M	-0.06M	0.11M	0.02M	1.83M	-1.96M	0.63M	0.41M	3.24M		0.02M	0.07M	-0.09M		0.20M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
Net Equity Issued and Repurchased (Quarter)																			20.58M
Misc.
Cash from Financing Activities (Quarter)	0.31M	0.03M	0.11M	0.13M	0.06M	-0.05M	66.39M	0.11M	-0.09M	-1.84M	94.30M	-6.52M	0.40M	0.13M	190.06M	0.00M	0.05M	9.71M	20.66M	0.20M
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)	-14.16M	-9.31M	-12.46M	-14.41M	-50.53M	-37.19M	113.61M	-13.48M	-9.49M	-13.49M	103.16M	1.76M	-39.11M	-44.40M	69.95M	-65.81M	-11.96M	12.19M	32.84M	20.32M
Free Cash Flow (Quarter)	-12.90M	-8.63M	-12.28M	-14.18M	-11.89M	-9.61M	-19.35M	-13.58M	-9.43M	-11.63M	-17.10M	-21.79M	-16.28M	-15.74M	-17.52M	-21.55M	-19.57M	-19.63M	-16.49M	-26.38M
Net Cash Flow (Quarter)	-14.16M	-9.31M	-12.46M	-14.41M	-50.53M	-37.19M	113.63M	-13.48M	-9.51M	-13.47M	103.16M	1.76M	-39.11M	-44.40M	69.95M	-65.81M	-11.92M	12.20M	32.80M	20.34M

Research Tools

Developers

Neurogene Cash Flow Statement (2013-2026) | NGNE

Research Tools

Developers

Neurogene Cash Flow Statement (2013-2026) | NGNE

Create an account

Sign In

Reset Password